BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10649242)

  • 21. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
    Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
    Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer.
    Tamoto E; Tada M; Murakawa K; Takada M; Shindo G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Kawakami A; Fujiwara Y; Kobayashi N; Shirata K; Nishimura N; Okushiba S; Kondo S; Hamada J; Yoshiki T; Moriuchi T; Katoh H
    Clin Cancer Res; 2004 Jun; 10(11):3629-38. PubMed ID: 15173069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
    Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.
    Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Ohno Y; Suzuki N; Inoue M; Soma G; Nagasue N
    Anticancer Res; 2005; 25(1B):463-70. PubMed ID: 15816613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC; Barnetson RS; Halliday GM
    Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma.
    Hughes SJ; Nambu Y; Soldes OS; Hamstra D; Rehemtulla A; Iannettoni MD; Orringer MB; Beer DG
    Cancer Res; 1997 Dec; 57(24):5571-8. PubMed ID: 9407969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
    Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
    Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fas and WAF1 expression in esophageal squamous cell carcinomas.
    Vlachos K; Siafakas N; Karameris A; Athanasas G; Theodoropoulos G; Parassi E; Peros G; Papadopoulos J; Hakim N
    Int Surg; 2006; 91(6):320-5. PubMed ID: 17256429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of metallothionein and FasL in colorectal cancer and its clinical significance].
    Li SY; Yu B; An P; Zuo FY; Cai HY
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1118-20. PubMed ID: 16194308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
    Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
    Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential chemokine, chemokine receptor, cytokine and cytokine receptor expression in pulmonary adenocarcinoma: diffuse down-regulation is associated with immune evasion and brain metastasis.
    Ohshima K; Hamasaki M; Makimoto Y; Yoneda S; Fujii A; Takamatsu Y; Nakashima M; Watanabe T; Kawahara K; Kikuchi M; Shirakusa T
    Int J Oncol; 2003 Oct; 23(4):965-73. PubMed ID: 12963975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.
    Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
    Gynecol Oncol; 2005 Jun; 97(3):772-9. PubMed ID: 15943986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
    J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence.
    Belluco C; Esposito G; Bertorelle R; Alaggio R; Giacomelli L; Bianchi LC; Nitti D; Lise M
    Eur J Surg Oncol; 2002 Mar; 28(2):120-5. PubMed ID: 11884046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells.
    Yoshinaga K; Yamashita K; Mimori K; Tanaka F; Inoue H; Mori M
    Ann Surg Oncol; 2008 Jan; 15(1):96-103. PubMed ID: 17909904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
    O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
    J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.